These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16891763)

  • 1. The effects of HMG-CoA reductase inhibitor on vascular progenitor cells.
    Kusuyama T; Omura T; Nishiya D; Enomoto S; Matsumoto R; Murata T; Takeuchi K; Yoshikawa J; Yoshiyama M
    J Pharmacol Sci; 2006 Aug; 101(4):344-9. PubMed ID: 16891763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation of functional endothelial progenitor cells from human umbilical cord blood mononuclear cells isolated by a novel cell filtration device.
    Aoki M; Yasutake M; Murohara T
    Stem Cells; 2004; 22(6):994-1002. PubMed ID: 15536190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two types of circulating endothelial progenitor cells in patients receiving long term therapy by HMG-CoA reductase inhibitors.
    Deschaseaux F; Selmani Z; Falcoz PE; Mersin N; Meneveau N; Penfornis A; Kleinclauss C; Chocron S; Etievent JP; Tiberghien P; Kantelip JP; Davani S
    Eur J Pharmacol; 2007 May; 562(1-2):111-8. PubMed ID: 17320859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway.
    Dimmeler S; Aicher A; Vasa M; Mildner-Rihm C; Adler K; Tiemann M; Rütten H; Fichtlscherer S; Martin H; Zeiher AM
    J Clin Invest; 2001 Aug; 108(3):391-7. PubMed ID: 11489932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow molecular alterations after myocardial infarction: Impact on endothelial progenitor cells.
    Thum T; Fraccarollo D; Galuppo P; Tsikas D; Frantz S; Ertl G; Bauersachs J
    Cardiovasc Res; 2006 Apr; 70(1):50-60. PubMed ID: 16480696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells.
    Llevadot J; Murasawa S; Kureishi Y; Uchida S; Masuda H; Kawamoto A; Walsh K; Isner JM; Asahara T
    J Clin Invest; 2001 Aug; 108(3):399-405. PubMed ID: 11489933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins, HMG-CoA Reductase Inhibitors, Improve Neovascularization by Increasing the Expression Density of CXCR4 in Endothelial Progenitor Cells.
    Chiang KH; Cheng WL; Shih CM; Lin YW; Tsao NW; Kao YT; Lin CT; Wu SC; Huang CY; Lin FY
    PLoS One; 2015; 10(8):e0136405. PubMed ID: 26309120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased VEGFR2 expression during human late endothelial progenitor cells expansion enhances in vitro angiogenesis with up-regulation of integrin alpha(6).
    Smadja DM; Bièche I; Helley D; Laurendeau I; Simonin G; Muller L; Aiach M; Gaussem P
    J Cell Mol Med; 2007; 11(5):1149-61. PubMed ID: 17979890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coadministration of endothelial and smooth muscle progenitor cells enhances the efficiency of proangiogenic cell-based therapy.
    Foubert P; Matrone G; Souttou B; Leré-Déan C; Barateau V; Plouët J; Le Ricousse-Roussanne S; Lévy BI; Silvestre JS; Tobelem G
    Circ Res; 2008 Sep; 103(7):751-60. PubMed ID: 18723447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of bone morphogenetic protein 2 in the crosstalk between endothelial progenitor cells and mesenchymal stem cells.
    Raida M; Heymann AC; Günther C; Niederwieser D
    Int J Mol Med; 2006 Oct; 18(4):735-9. PubMed ID: 16964430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mobilization of endothelial progenitor cells in fracture healing and distraction osteogenesis.
    Lee DY; Cho TJ; Kim JA; Lee HR; Yoo WJ; Chung CY; Choi IH
    Bone; 2008 May; 42(5):932-41. PubMed ID: 18326482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin ameliorates hypoxia-induced pulmonary hypertension associated with down-regulated stromal cell-derived factor-1.
    Satoh K; Fukumoto Y; Nakano M; Sugimura K; Nawata J; Demachi J; Karibe A; Kagaya Y; Ishii N; Sugamura K; Shimokawa H
    Cardiovasc Res; 2009 Jan; 81(1):226-34. PubMed ID: 18779230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors.
    Urbich C; Dimmeler S
    Kidney Int; 2005 May; 67(5):1672-6. PubMed ID: 15840010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of glyceollins on vasculogenesis through suppression of endothelial progenitor cell function.
    Choi JH; Nguyen MP; Jung SY; Kwon SM; Jee JG; Bae JS; Lee S; Lee MY; Lee YM
    Mol Nutr Food Res; 2013 Oct; 57(10):1762-71. PubMed ID: 23784812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide-1 improves proliferation and differentiation of endothelial progenitor cells via upregulating VEGF generation.
    Xiao-Yun X; Zhao-Hui M; Ke C; Hong-Hui H; Yan-Hong X
    Med Sci Monit; 2011 Feb; 17(2):BR35-41. PubMed ID: 21278683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tumour necrosis factor-alpha on activity and nitric oxide synthase of endothelial progenitor cells from peripheral blood.
    Chen TG; Zhong ZY; Sun GF; Zhou YX; Zhao Y
    Cell Prolif; 2011 Aug; 44(4):352-9. PubMed ID: 21702858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of lysophosphatidylcholine on survival and function of UEA-1(+)acLDL (+) endothelial progenitor cells in patients with coronary artery disease.
    Hong SH; Jang HH; Lee SR; Lee KH; Woo JS; Kim JB; Kim WS; Min BI; Cho KH; Kim KS; Cheng X; Kim W
    Heart Vessels; 2015 Jan; 30(1):115-25. PubMed ID: 24510253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial progenitor cells derived from CD34+ cells form cooperative vascular networks.
    Guo S; Cheng Y; Ma Y; Yang X
    Cell Physiol Biochem; 2010; 26(4-5):679-88. PubMed ID: 21063105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor-A signaling in bone marrow-derived endothelial progenitor cells exposed to hypoxic stress.
    Hoffmann BR; Wagner JR; Prisco AR; Janiak A; Greene AS
    Physiol Genomics; 2013 Nov; 45(21):1021-34. PubMed ID: 24022223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginsenoside Rg3 inhibits endothelial progenitor cell differentiation through attenuation of VEGF-dependent Akt/eNOS signaling.
    Kim JW; Jung SY; Kwon YH; Lee SH; Lee JH; Lee BY; Kwon SM
    Phytother Res; 2012 Sep; 26(9):1286-93. PubMed ID: 22253055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.